Polio endgame: the global switch from tOPV to bOPV
- PMID: 26751187
- DOI: 10.1586/14760584.2016.1140041
Polio endgame: the global switch from tOPV to bOPV
Abstract
Globally, polio cases have reached an all-time low, and type 2 poliovirus (one of three) is eradicated. Oral polio vaccine (OPV) has been the primary tool, however, in rare cases, OPV induces paralysis. In 2013, the World Health Assembly endorsed the phased withdrawal of OPV and introduction of inactivated poliovirus vaccine (IPV) into childhood routine immunization schedules. Type 2 OPV will be withdrawn through a globally synchronized "switch" from trivalent OPV (all three types) to bivalent OPV (types 1 and 3). The switch will happen in 155 OPV-using countries between April 17(th) and May 1(st), 2016. Planned activities to reduce type 2 outbreak risks post-switch include the following: tOPV campaigns to increase type 2 immunity prior to the switch, monovalent OPV2 stockpiling to respond to outbreaks should they occur, containment of both wild and vaccine type 2 viruses, enhanced acute flaccid paralysis (AFP) and environmental surveillance, outbreak response protocols, and ensured access to IPV and bivalent OPV.
Keywords: eradication; immunization; inactivated polio vaccine; oral polio vaccine; polio; poliomyelitis; switch.
Similar articles
-
India's Preparedness for Introduction of IPV and Switch from tOPV to bOPV.Indian Pediatr. 2016 Aug 7;53 Suppl 1:S44-S49. Indian Pediatr. 2016. PMID: 27771639
-
Polio endgame: the global introduction of inactivated polio vaccine.Expert Rev Vaccines. 2015 May;14(5):749-62. doi: 10.1586/14760584.2015.1001750. Epub 2015 Jan 19. Expert Rev Vaccines. 2015. PMID: 25597843 Review.
-
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.BMC Infect Dis. 2016 Jun 1;16:237. doi: 10.1186/s12879-016-1537-8. BMC Infect Dis. 2016. PMID: 27246198 Free PMC article.
-
Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.J Infect Dis. 2017 Jul 1;216(suppl_1):S183-S192. doi: 10.1093/infdis/jiw626. J Infect Dis. 2017. PMID: 28838179 Free PMC article.
-
Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.Clin Infect Dis. 2018 Oct 30;67(suppl_1):S35-S41. doi: 10.1093/cid/ciy633. Clin Infect Dis. 2018. PMID: 30376081 Free PMC article. Review.
Cited by
-
Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019.Biomed Res Int. 2024 Oct 4;2024:5515777. doi: 10.1155/2024/5515777. eCollection 2024. Biomed Res Int. 2024. PMID: 39399343 Free PMC article.
-
The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India.Vaccines (Basel). 2024 Apr 17;12(4):424. doi: 10.3390/vaccines12040424. Vaccines (Basel). 2024. PMID: 38675806 Free PMC article.
-
Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children.Front Public Health. 2024 Mar 27;12:1384410. doi: 10.3389/fpubh.2024.1384410. eCollection 2024. Front Public Health. 2024. PMID: 38601488 Free PMC article.
-
Immune persistence after different polio sequential immunization schedules in Chinese infants.NPJ Vaccines. 2024 Feb 29;9(1):50. doi: 10.1038/s41541-024-00831-1. NPJ Vaccines. 2024. PMID: 38424078 Free PMC article.
-
Assessment of open data kit mobile technology adoption to enhance reporting of supportive supervision conducted for oral poliovirus vaccine supplementary immunization activities in Nigeria, March 2017-February 2020.Pan Afr Med J. 2023 Jul 14;45(Suppl 2):5. doi: 10.11604/pamj.supp.2023.45.2.38140. eCollection 2023. Pan Afr Med J. 2023. PMID: 38370103 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous